Exploratory study | PDAC | CP | LC | BD |
---|---|---|---|---|
n | ||||
Total | 34 | 43 | 20 | 104 |
Male | 15 | 36 | 15 | 49 |
Female | 19 | 7 | 5 | 55 |
Age, years | ||||
Median | 64 | 50 | 56 | 53 |
IQR | 59–71 | 44–57 | 46–62 | 26–59 |
Stage | ||||
0 | 0 | |||
IA | 0 | |||
IB | 1 | |||
IIA | 4 | |||
IIB | 8 | |||
III | 11 | |||
IV | 10 | |||
Histology/cytology | ||||
Ductal adenocarcinoma | 34 | |||
Identification study | PDAC | CP | LC | BD |
n | ||||
Total | 158 | 159 | 80 | 77 |
Male | 102 | 136 | 60 | 51 |
Female | 56 | 23 | 20 | 26 |
Age, year | ||||
Median | 70 | 50 | 61 | 55 |
IQR | 62–74 | 45–55 | 49–69 | 52–58 |
Stage | ||||
IA | 2 | |||
IB | 3 | |||
IIA | 18 | |||
IIB | 59 | |||
III | 22 | |||
IV | 54 | |||
Histology/cytology | ||||
Ductal adenocarcinoma | 158 | |||
Validation study | PDAC | CP | Controls | |
Group | ||||
n | ||||
Total | 79 | 80 | 80 | |
Male | 37 | 62 | 42 | |
Female | 42 | 18 | 38 | |
Age, years | ||||
Median | 69 | 51 | 68 | |
IQR | 61–74 | 46–57 | 55–74 | |
Stage | ||||
IA | 1 | |||
IB | 0 | |||
IIA | 11 | |||
IIB | 28 | |||
III | 26 | |||
IV | 13 | |||
Histology/cytology | ||||
Ductal adenocarcinoma | 79 |
BD, blood donor; control, non-pancreatic disease; CP, chronic pancreatitis; LC, liver cirrhosis; PDAC, pancreatic ductal adenocarcinoma.